The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...

Truist Financial analyst Les Sulewski maintained a Hold rating on ANI Pharmaceuticals today and set a price target of $66.77. The company’s shares closed yesterday at $66.77. Take advantage of ...